This next article in our series aims to provide an overview of incretins, examine the effects they exert on the body, and discuss their potential in the treatment of conditions associated with chronic inflammation
Your provider may need to determine you aren't a suitable candidate for a brand-name GLP-1, for reasons such as an allergy to an ingredient in a brand-name med
Our speakers will delve into critical topics such as the FDAs current stance on peptide compounding, recent pronouncements from state Boards of Pharmacy, and the intricate legalities surrounding brand manufacturers
The most frequently reported adverse effects relate to the gastrointestinal system rather than direct cardiac effects, including nausea (occurring in approximately 15-20% of patients according to the SmPC), vomiting, diarrhoea, and constipation
The findings of the study were